SCHEMBL3593253

SCHEMBL3593253

CCc1cc(C(=O)c2ccc(OC(F)(F)F)cc2)c(NC(=O)COc2ccc(OCC(=O)O)cc2)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.59
GFER P55789 1/20 0.58
ALDH1A1 P00352 7/20 0.51
MAPT P10636 4/20 0.51
LMNA P02545 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
KDM4E B2RXH2 6/20 0.51
GAA P10253 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
POLB P06746 2/20 0.50
HPGD P15428 2/20 0.47
GLA P06280 1/20 0.47
THRB P10828 1/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585588 0.92 NPSR1 (0.54) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3590071 0.90 NPSR1 (0.53) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3588145 0.87 NPSR1 (0.63) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3586151 0.86 NPSR1 (0.50) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3587540 0.85 NPSR1 (0.68) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3591422 0.85 GFER (0.80) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3589449 0.85 NPSR1 (0.59) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL14160313 0.85 GFER (0.58) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL13462108 0.84 GFER (0.55) NPSR1GFERALDH1A1MAPTLMNA
SCHEMBL3581685 0.84 GFER (0.57) NPSR1GFERALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US claimed
WO-2007036730-A9 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LTD (GB) 2008-06-19 WO claimed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed
EP-1937663-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I Inpharmatica Limited (GB) 2008-07-02 EP disclosed
WO-2007036730-A9 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LTD (GB) 2008-06-19 WO disclosed
WO-2007036730-A9 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LTD (GB) 2008-06-19 WO disclosed
WO-2007036730-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2007-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I PPARG, PPARD, PPARA NPSR1 706/4885GFER 996/4885ALDH1A1 1049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.